BEST QUALITY SUPPLYER MOST PROFESSIONAL 10-Deacetylbaccatin III (32981-86-5) IN bulk

Chemical Structure: 10-Deacetylbaccatin III is a natural product, a precursor of paclitaxel (Taxol), which is a well-known anticancer drug. It is a complex diterpenoid compound with a molecular formula of C29H36O10.

Isolation: 10-Deacetylbaccatin III is isolated from the needles of the Taxus species, primarily Taxus baccata (European yew) and Taxus brevifolia (Pacific yew), as well as other Taxus species.

Biological Importance: It plays a crucial role as a precursor in the semi-synthesis of paclitaxel, a potent chemotherapy medication used to treat various cancers, including breast, ovarian, and lung cancers.

Chemical Transformation: Through chemical synthesis or semi-synthesis, 10-Deacetylbaccatin III can be converted into paclitaxel by acetylation at the C10 position, leading to the formation of the key pharmacophore of paclitaxel.

Medicinal Uses: While 10-Deacetylbaccatin III itself is not used directly as a medication, its conversion into paclitaxel makes it invaluable in the pharmaceutical industry for the production of paclitaxel-based chemotherapy drugs.

Anticancer Activity: Paclitaxel, derived from 10-Deacetylbaccatin III, acts by stabilizing microtubules in cancer cells, preventing their breakdown during cell division, and ultimately leading to cell death. This mechanism makes paclitaxel highly effective against rapidly dividing cancer cells.

Semi-Synthesis of Paclitaxel: The semi-synthesis of paclitaxel from 10-Deacetylbaccatin III involves several chemical steps, including acetylation at the C10 position, oxidation of the C9 position, and other modifications to yield the final product.

Pharmaceutical Importance: Paclitaxel and its derivatives, produced from 10-Deacetylbaccatin III, are among the most widely used chemotherapy agents worldwide and are essential in the treatment of various types of cancer.

Research and Development: Ongoing research is focused on developing more efficient and sustainable methods for the production of paclitaxel and its derivatives from 10-Deacetylbaccatin III, as well as exploring its potential in the treatment of other diseases.

Natural Source: The Taxus species, from which 10-Deacetylbaccatin III is obtained, are cultivated or harvested for their bark, leaves, and needles, which contain valuable compounds used in cancer treatment and research.

Chemical Characterization: The structure of 10-Deacetylbaccatin III has been elucidated through various spectroscopic techniques, including nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry.

Synthetic Biology: Advances in synthetic biology and genetic engineering have enabled the production of 10-Deacetylbaccatin III and its derivatives through microbial fermentation or plant cell culture, providing alternative sources for its production.

Market Demand: Given the significant demand for paclitaxel and its derivatives in the pharmaceutical industry, 10-Deacetylbaccatin III remains a valuable natural product with a substantial market value.

Regulatory Considerations: The production and use of 10-Deacetylbaccatin III and its derivatives are subject to regulatory oversight by health authorities to ensure their safety, efficacy, and quality in pharmaceutical applications.

Future Prospects: As research continues to unravel the therapeutic potential of paclitaxel and explore new avenues for its use in cancer treatment and other diseases, the importance of 10-Deacetylbaccatin III as a precursor will likely continue to grow, driving further innovation in drug development and production processes.